Semaglutide falls under a class of medications known as glucagon-like peptide-1 receptor agonists, or GLP-1s, which mimic the GLP-1 hormone produced in the gut after eating
This article examines the evidence, potential mechanisms, and appropriate management strategies for palpitations during semaglutide therapy
Oral form (Rybelsus): This is a daily tablet that dissolves in the stomach before being absorbed
Lupus patients should be counselled to: Maintain adequate hydration , particularly if experiencing nausea, vomiting, or diarrhoea, as dehydration poses particular risks for those with kidney involvement Seek immediate medical attention if they develop symptoms suggestive of pancreatitis (persistent, severe abdominal pain, sometimes radiating to the back) or gallbladder disease Contact their GP or rheumatology team promptly if they develop new symptoms that could indicate either lupus flare or medication complications (signs of infection, new rashes, joint swelling) Never adjust or discontinue lupus medications without medical guidance, even if experiencing side effects from Wegovy Report any difficulty taking oral medications due to nausea, as this may affect immunosuppressant levels If concerning symptoms develop, treatment should be reviewed promptly
Findings Overall, 415 participants were included for analysis
